Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
Seoane-Viaño I, Gómez-Lado N, Lázare-Iglesias H, Barreiro-de Acosta M, Silva-Rodríguez J, Luzardo-Álvarez A, Herranz M, Otero-Espinar F, Antúnez-López JR, Lamas MJ, Aguiar P, Fernández-Ferreiro A, Ruibal Á. Seoane-Viaño I, et al. Int J Pharm. 2018 Oct 5;549(1-2):335-342. doi: 10.1016/j.ijpharm.2018.08.005. Epub 2018 Aug 3. Int J Pharm. 2018. PMID: 30081226
Characteristics and Progression of Preclinical Inflammatory Bowel Disease.
Rodríguez-Lago I, Merino O, Azagra I, Maiz A, Zapata E, Higuera R, Montalvo I, Fernández-Calderón M, Arreba P, Carrascosa J, Iriarte A, Portillo I, Aguirre U, Barreiro-de Acosta M, Muñoz-Navas M, Cabriada JL. Rodríguez-Lago I, et al. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1459-1466. doi: 10.1016/j.cgh.2017.11.006. Epub 2017 Nov 11. Clin Gastroenterol Hepatol. 2018. PMID: 29133254
Radon exposure and inflammatory bowel disease in a radon prone area.
Mauriz-Barreiro V, Barreiro-de Acosta M, Bastón-Rey I, Ferreiro-Iglesias R, Calviño-Suárez C, Barros-Dios JM, Domínguez-Munoz JE, Ruano-Raviña A. Mauriz-Barreiro V, et al. Rev Esp Enferm Dig. 2022 Jul;114(7):405-409. doi: 10.17235/reed.2021.8239/2021. Rev Esp Enferm Dig. 2022. PMID: 34781685
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA.
Toja-Camba FJ, García-Quintanilla L, Rodríguez-Martinez L, Tomine J, Cajade-Pascual F, Feitosa C, Zarra-Ferro I, Barreiro-De-Acosta M, González-López J, Mondelo-García C, Fernández-Ferreiro A. Toja-Camba FJ, et al. Pharmaceutics. 2023 Nov 11;15(11):2615. doi: 10.3390/pharmaceutics15112615. Pharmaceutics. 2023. PMID: 38004593 Free PMC article.
237 results